CureVac is a global biopharmaceutical company with more than 20 years of experience in developing the mRNA technology for medical purposes.
CureVac
Biotech company
CureVac N.V. is a German biopharmaceutical company. It develops therapies based on messenger RNA. Headquartered in Tübingen, Germany, the company was founded in 2000 by Ingmar Hoerr, Steve Pascolo, Florian von der Mulbe, Günther Jung, and... Wikipedia
CEO: Alexander Zehnder (Apr 2023–)
Founders: Ingmar Hoerr, Steve Pascolo, Florian von der Mülbe, and more
CFO: Pierre Kemula
Headquarters: Tübingen, Germany
Founded: 2000
Number of employees: < 700
People also ask
Does CureVac have a COVID vaccine?
Who are the shareholders of CureVac?
What is the history of CureVac?
Where is CureVac located?
CureVac N.V. is a German biopharmaceutical company. It develops therapies based on messenger RNA (mRNA). Headquartered in Tübingen, Germany, the company was ...
Prophylactic vaccines, cancer therapies & molecular therapies: CureVac is a leader & pioneer in developing medicines based on mRNA. https://t.co/8NlCE03ZY6.
Mar 7, 2023 · CureVac (Nasdaq: CVAC) is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of ...
4 days ago · CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid ...
Feb 3, 2021 · This collaboration will build on CureVac's first generation COVID-19 vaccine candidate CVnCoV, which is currently in Phase 2b/3 clinical trial ...
Dec 19, 2023 · A regional German court in September put on hold a separate patent infringement trial brought by CureVac against BioNTech over the use of mRNA ...